MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon

23rd October 2009 LOUISVILLE, Kentucky, October 23 /PRNewswire/ -- -- Alcon takes over development of POT-4 as a treatment for patients with age-related macular degeneration -- Deal provides path for Alcon to acquire Potentia more

More Than 35 Million People Have Alzheimer's and Dementia Worldwide, According To New Report

21st September 2009 NEW YORK, September 21 /PRNewswire/ -- More than 35 million people worldwide will have dementia in 2010, according to the 2009 World Alzheimer's Report from Alzheimer's Disease International (ADI). The new report was released on September 21st, which is World Alzheimer's Day. This is a 10 percent increase over previous global dementia prevalence reported in 2005 in The Lancet. According to the new report, dementia prevalence will nearly double every 20 years, to 65.7 million in 2030... more

Patients Fear Osteoporosis Quality of Life Impact, Yet Lack Tools to Manage Concerns and Improve Osteoporosis Outcomes, New Survey Says

14th September 2009 DENVER, September 14 /PRNewswire/ -- The International Osteoporosis Foundation (IOF) today announced results from a new multinational survey of patients (n= 844; women 55+ with post menopausal osteoporosis) and physicians (n= 837; general practitioners and specialists treating osteoporosis) at the 31st annual meeting of the American Society of Mineral and Bone Research (ASBMR). Results show that patients fear the impact of osteoporosis on quality of life, such as breaking a bone and reduced... more
Senior Citizens RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

Royal Pharmaceutical Society Calls for Older People to Review Their Medicine With a Pharmacist
28th July 2009 LONDON, July 29 /PRNewswire/ -- New research released today by the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals how older people are taking a cocktail of medicine without fully...

Frost & Sullivan Examines the Key Challenges in the European Non-Invasive Ventilation Market
21st July 2009 LONDON, July 21 /PRNewswire/ -- Europe's aging population has led to a rise in the number of registrations and diagnoses of respiratory diseases. While there has been a shift towards non-invasive...

Canadian Researchers Discover Gene Related to the Appearance of Aging
15th July 2009 HALIFAX, Canada, July 15 /PRNewswire/ -- Scientists in Atlantic Canada have found a gene that may play a role in skin aging. Researchers were investigating the genetic cause of a rare disorder known...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
14th July 2009 VIENNA, July 14 /PRNewswire/ -- Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's...

Majority of Physicians,(1) Alzheimer's Disease (AD) Carers(1) and the General Public(1) in Five European Countries Understand the Need to Detect and Treat AD Early, Yet the Disease Remains Significantly Under-Diagnosed(2)
13th July 2009 VIENNA, July 13 /PRNewswire/ -- A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in the United Kingdom, France, Italy, Spain...

A Supplement a Day May Help Keep Falls at Bay
24th June 2009 BASINGSTOKE, England, June 24 /PRNewswire/ -- As National Falls Awareness Day takes place this week, a new programme called 'Be Active' is being launched to help those already prescribed bone health...

Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
11th June 2009 SEATTLE, June 11 /PRNewswire/ -- Neurim Pharmaceuticals (http://www.neurim.com) presented today the preliminary results of a large-scale Phase III study of Circadin(R) 2mg, prolonged release...

NICE Acknowledge Alzheimer's Model Faulty but do not Plan to Change Recommendations
10th June 2009 LONDON, June 11 /PRNewswire/ -- Eisai Limited, the licence holder of Aricept(R) (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, have been notified by the National Institute...

Dutch Fairytale Becomes Reality
22nd April 2009 AMSTERDAM, April 22 /PRNewswire/ -- An old Dutch wish for becomes reality: "De Belevenis" is a full-fledged entertainment centre for people with multiple severe handicaps and the elderly who suffer...

Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
15th December 2008 NAPA, California, December 15 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy...

Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
11th November 2008 LOUISVILLE, Kentucky, November 11 /PRNewswire/ -- Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD),...

Hope for Mild Alzheimer's Patients as House of Lords Refuses to Hear NICE's Appeal
29th October 2008 LONDON, October 29 /PRNewswire/ -- Eisai Limited, the licence holder of Aricept(R) (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, welcome the announcement by the House of...

The Y Lift
28th October 2008 NEW YORK, October 28 /PRNewswire/ -- Yan Trokel, MD, is revolutionizing the field of aesthetic surgery with the Y Lift, a new proven, non-invasive procedure that restores and improves the appearance...

Ageing Populations Face Crisis of Rising Blindness
4th October 2008 LONDON, October 4 /PRNewswire/ -- The world's populations are ageing rapidly, bringing greater risk of blindness and vision impairment to millions. Around the world, organisations of many kinds are...

ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease
7th August 2008 KIRKLAND, Washington, August 7 /PRNewswire/ -- ProteoTech Inc. (ProteoTech) today announced that it has completed regulatory Investigational New Drug (IND) requirements and has been cleared by the...

Survey Paints Bleak Picture of Funding for Continence Care Services
29th July 2008 LONDON, July 29 /PRNewswire/ -- A recent AHPMA survey among continence care professionals has painted a bleak picture on the current state of many continence services in the UK, largely due to lack...

Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
1st July 2008 NAPA, California, July 1 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Biobusiness 2009
Profile your company today
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us